Acurx Pharmaceuticals Inc. (NASDAQ: ACXP)
$0.7672
+0.0087 ( -2.89% ) 46.6K
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Market Data
Open
$0.7672
Previous close
$0.7585
Volume
46.6K
Market cap
$13.31M
Day range
$0.7730 - $0.8400
52 week range
$0.7200 - $5.2800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Nov 13, 2024 |
| 10-q | Quarterly Reports | 51 | Nov 12, 2024 |
| 8-k | 8K-related | 14 | Aug 09, 2024 |
| 10-q | Quarterly Reports | 54 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 8-k | 8K-related | 13 | Jun 17, 2024 |